Agonist IgM: Anti-Death Receptor 5 IgM Induces Tumor Cell Apoptosis in vitro and in vivo with a Favorable Safety Profile

Posted on November 12, 2020November 11, 2020 by jean kanerva

PEGS Europe Virtual – November 12, 2020
Program: Novel Targets and Emerging Therapeutic Areas

Bruce Keyt, PhD, Chief Scientific Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

Posted in publications.